In the last years it splut twice which made the OS

In the last years it splut twice which made the OS and float bigger while it did that, it kept shorting. I keot track of this stock however, i bought this at .0217 and sold at .096 and then rebought all again @ .051. Havent sold it ever since then, .205 is still not enough. June 23rd 2017 the clinical trials got approved and waiting for trial 3. Either or a buy out or a JV will happen this stock is still worth to much money.